SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $11,545,000 | +19.0% | 1,030,748 | +16.9% | 0.01% | +7.7% |
Q2 2017 | $9,701,000 | +15.2% | 881,896 | +2.7% | 0.01% | +18.2% |
Q1 2017 | $8,419,000 | -6.8% | 859,048 | +2.7% | 0.01% | -8.3% |
Q4 2016 | $9,037,000 | +0.3% | 836,809 | -4.8% | 0.01% | -14.3% |
Q3 2016 | $9,008,000 | +23.0% | 878,867 | +56.7% | 0.01% | +7.7% |
Q2 2016 | $7,326,000 | -5.1% | 560,973 | -20.1% | 0.01% | -7.1% |
Q1 2016 | $7,721,000 | -4.3% | 701,876 | -20.0% | 0.01% | 0.0% |
Q4 2015 | $8,069,000 | +50.8% | 877,076 | +13.7% | 0.01% | +27.3% |
Q3 2015 | $5,351,000 | -2.5% | 771,086 | +38.0% | 0.01% | 0.0% |
Q2 2015 | $5,488,000 | +192.1% | 558,851 | +163.5% | 0.01% | +175.0% |
Q1 2015 | $1,879,000 | +391.9% | 212,109 | +386.5% | 0.00% | +300.0% |
Q4 2014 | $382,000 | +297.9% | 43,600 | +213.7% | 0.00% | – |
Q3 2014 | $96,000 | -37.7% | 13,900 | -52.5% | 0.00% | – |
Q2 2014 | $154,000 | -68.3% | 29,280 | -72.6% | 0.00% | -100.0% |
Q1 2014 | $486,000 | -57.7% | 106,880 | -53.1% | 0.00% | -66.7% |
Q4 2013 | $1,149,000 | -37.8% | 227,980 | -37.4% | 0.00% | -57.1% |
Q3 2013 | $1,847,000 | -52.0% | 364,380 | -53.0% | 0.01% | -50.0% |
Q2 2013 | $3,846,000 | +67.6% | 775,400 | +45.6% | 0.01% | +40.0% |
Q4 2012 | $2,295,000 | – | 532,500 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 1,249,200 | $13,491,000 | 8.04% |
Nantahala Capital Management | 2,169,043 | $23,426,000 | 2.43% |
Sensato Investors LLC | 429,069 | $4,634,000 | 0.80% |
TFS CAPITAL LLC | 144,575 | $1,561,000 | 0.42% |
Sapphire Star Partners LP | 27,938 | $302,000 | 0.34% |
Ativo Capital Management LLC | 123,428 | $1,333,000 | 0.31% |
Zebra Capital Management LLC | 55,618 | $601,000 | 0.18% |
MENTA CAPITAL LLC | 191,474 | $2,068,000 | 0.17% |
GSA CAPITAL PARTNERS LLP | 231,214 | $2,497,000 | 0.15% |
ACADIAN ASSET MANAGEMENT LLC | 1,919,172 | $20,729,000 | 0.10% |